Duke researchers identify new cancer treatment

Jun. 18, 2014 @ 10:34 AM

Duke Medicine researchers identified a new strategy for treating a nerve tissue cancer with modified heparin.

In a study conducted in mice and published June 17 in the Journal of Clinical Investigation, researchers found that when the century-old injectable drug is altered to remove its blood-thinning properties, it shrinks neuroblastoma tumors without causing severe bleeding.

Neuroblastoma is rare overall, but the most common cancer in infants, according to the American Cancer Society.